Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
19.23
-0.52 (-2.63%)
Aug 7, 2026, 2:38 PM EDT - Market open
Relay Therapeutics Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Relay Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $26.08. The average 1-year stock price forecast is 35.62% higher than the current stock price, while the lowest is $20 (+4.00%) and the highest is $32 (+66.41%).
Price Target: $26.08 (+35.62%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 11 | 10 | 11 | 11 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 13 | 13 | 12 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $27 → $30 | Buy | Maintains | $27 → $30 | +56.01% | Aug 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 7, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $20 | Buy | Maintains | $20 | +4.00% | Aug 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 4, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $22 → $31 | Buy | Maintains | $22 → $31 | +61.21% | Jul 21, 2026 |
Financial Forecast
Revenue This Year
11.80M
from 15.36M
Decreased by -23.12%
Revenue Next Year
14.50M
from 11.80M
Increased by 22.84%
EPS This Year
-1.53
from -1.61
EPS Next Year
-1.64
from -1.53
EPS and Forward PE are based on non-GAAP adjusted numbers.